Author: Dr. David Lowemann

FDA Approves Eli Lilly’s Drug for Eczema

Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above 12 years old. The drug, branded Ebglyss, will be available in the next few weeks, the company said. The FDA’s approval was based on three studies… Read Full Article (External Site) Dr. David […]

Published on September 13, 2024

1 in 3 Cinnamon Products Have High Lead Levels

One third of cinnamon products tested by Consumer Reports contained elevated levels of lead, the watchdog agency warned Thursday. The finding follows concerns about metals in foods after tainted cinnamon applesauce poisoned hundreds in 44 states last year, most of them… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on September 13, 2024

Babies born to women consuming a high fat, sugary diet at greater risk of cardiovascular disease and diabetes in later life

Babies born to pregnant women with obesity are more likely to develop heart problems and diabetes as adults due to fetal damage caused by the high-fat, high-energy diet of their mother. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, […]

Published on September 13, 2024